Seattle researchers map genome of advanced, lethal prostate cancers and discover "hypermutations":

Seattle researchers map genome of advanced, lethal prostate cancers and discover “hypermutations”: NCI Cancer Center News A team of researchers at Fred Hutchinson Cancer Research Center and the University of Washington has conducted the first comprehensive assessment of every gene in the genome of advanced, lethal prostate cancer. Until now, the genetic composition of such tumors … Continue reading “Seattle researchers map genome of advanced, lethal prostate cancers and discover "hypermutations":”

Seattle researchers map genome of advanced, lethal prostate cancers and discover “hypermutations”: NCI Cancer Center News

A team of researchers at Fred Hutchinson Cancer Research Center and the University of Washington has conducted the first comprehensive assessment of every gene in the genome of advanced, lethal prostate cancer. Until now, the genetic composition of such tumors had been poorly defined… The researchers also have identified several instances of genetic “hypermutation,” a gross excess of single-letter DNA “spelling errors” that could cause the cancer to become resistant to therapies commonly used to slow the progression of advanced prostate cancer, such as androgen-blocking drugs and surgical castration.

Click here to read full press release from Fred Hutchinson Cancer Research Center.

###

Among the research institutions NCI funds across the United States, it currently designates 66 as Cancer Centers. Largely based in research universities, these facilities are home to many of the NCI-supported scientists who conduct a wide range of intense, laboratory research into cancer’s origins and development. The Cancer Centers Program also focuses on trans-disciplinary research, including population science and clinical research. The centers’ research results are often at the forefront of studies in the cancer field.

Author: Joe Lovrek

Born in Houston, Raised in Trinity Texas

Leave a Reply